Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olodaterol and BI 54903 FDC vs Free Combination in Asthma
NCT01428622Phase 2Withdrawn
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2011
- Countries
- 1
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Planned start Oct 2011; status: withdrawn.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01428622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428622.